CD79A and infection: Another potential method of identifying patients who may best benefit from IgM- and IgA-enriched immunoglobulin treatment could be the use of an adapted version of the predisposition, insult/infection, response and organ dysfunction (PIRO) score—the Torino (TO)-PIRO score [97].